{'fraction_non_alphanumeric': 0.02559867877786953, 'fraction_numerical': 0.013212221304706853, 'mean_word_length': 6.005780346820809, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Three methods compared for determining phosphatidylglycerol in amniotic fluid.

Phosphatidylglycerol is one component of amniotic fluid that is unaffected by several of the reported interferences with conventional thin-layer chromatographic measurement of phospholipid. To compare a rapid immunological agglutination test, "Amniostat-FLM", with two-dimensional thin-layer chromatography, we determined phosphatidylglycerol by both methods in 41 amniotic fluid specimens obtained at 31 to 40 weeks of gestation. We also assayed phosphatidylglycerol in 14 of these specimens by an enzymic, colorimetric procedure. The agglutination test is rapid and simple but relatively insensitive; it yielded positive results for only seven of 23 specimens in which phosphatidylglycerol was detected by thin-layer chromatography. In 18 specimens in which no phosphatidylglycerol was detected by thin-layer chromatography, results by Amniostat-FLM were also negative; however, eight of these specimens, assayed by the enzymic method, had phosphatidylglycerol present. Apparently, the Amniostat-FLM detects phosphatidylglycerol only at concentrations exceeding 25 mumol/L, or more than 15% of the total phospholipid composition.